Karl W. Lauterbach

Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf RECALL Study

Axel Schmermund, Stefan Möhlenkamp, Andreas Stang et al. · American Heart Journal · 2002 · 567 citations

Novel Risk Factors, Epidemiology, Cardiovascular Epidemiology +11

Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany

Markus Lüngen, Björn Stollenwerk, Philipp Messner et al. · International Journal for Equity in Health · 2008 · 179 citations · Full text

Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results

Markus Dietlein, Kerstin Weber, Afschin Gandjour et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 137 citations

Positron Emission Tomography, Nuclear Medicine, Nodal-negative Ct Results +11

German Diabetes Management Programs Improve Quality Of Care And Curb Costs

Stephanie Stock, Anna Drabik-Chamerska, Guido Büscher et al. · Health Affairs · 2010 · 125 citations

Family Medicine, Disease Management, Self-care Intervention +16

Asthma: prevalence and cost of illness

Stephanie Stock, Marcus Redaèlli, Markus Luengen et al. · European Respiratory Journal · 2005 · 124 citations · Full text